Joel Koppinger

Joel Koppinger serves as a Contract Specialist within the W6QK Acc-apg Durham office under the Department of the Army (W911NF), where he plays a pivotal role in executing mission-critical acquisitions to advance U.S. Army modernization. He specializes in procuring research and development services across physical, engineering, and life sciences, with a strong focus on disruptive technologies including autonomy, quantum systems, and intelligence horizon scanning. His acquisitions support high-priority R&D initiatives that bridge civilian innovation with defense applications, ensuring timely delivery of cutting-edge scientific capabilities through competitive, compliant, and strategically aligned contracting actions. While no specific contractor relationships are currently identifiable in the data, Koppinger engages with a diverse ecosystem of technical vendors, including defense contractors, academic research institutions, and specialized technology firms capable of delivering advanced R&D solutions. His procurement approach emphasizes performance-based outcomes, technical rigor, and risk mitigation, fostering long-term partnerships with firms possessing deep expertise in experimental systems development, sensor integration, and computational modeling. He routinely navigates complex technical requirements to ensure contract deliverables align with Army science and technology roadmaps. Koppinger’s contracting patterns reflect a strong preference for open competition, with 92.9% of awards issued without set-aside designation. The remaining 7.1% are allocated to HUBZone-certified small businesses, indicating a measured but intentional commitment to socioeconomic programs. Though not heavily reliant on set-asides, he ensures compliance with all applicable regulations and actively encourages small business participation where technical capability and mission alignment permit. His primary procurement focus lies in NAICS 541715 and 541712, encompassing non-biotech R&D in physical and engineering sciences, alongside significant activity in 334111 for electronic computer manufacturing and 541714 for biotechnology research. He routinely acquires advanced prototyping services, AI-driven analytics platforms, autonomous system components, and laboratory instrumentation, demonstrating deep domain expertise in next-generation defense science and technology acquisition.